{
    "type": "ETC",
    "ucits": false,
    "leverage": false,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Use of derivatives and structured products (Collateralized Loan Obligations), synthetic replication, complex payoff structure, counterparty risk, lack of capital protection, illiquidity due to exit costs, complex underlying index",
    "classification": "complex",
    "supporting_data": "The product described is an Open End Tracker Certificate linked to the UBS CMCI Zinc USD TR Index, issued by UBS AG London Branch. It is not a UCITS ETF but an Exchange Traded Certificate (ETC) with a synthetic structure involving derivatives. The product does not confer ownership rights in the underlying index components and relies on a predefined exercise procedure to realize returns. It embeds derivative exposure and structured product features, including counterparty risk and potential early termination risk by the issuer. The product is explicitly stated as 'not simple and may be difficult to understand' and is intended for investors with advanced knowledge and experience. The risk indicator is medium-high (5/7), reflecting significant market and issuer risks. The product does not offer capital protection and may incur significant losses, including total loss of capital. The use of derivatives is integral to the product's payoff, and the underlying index is a commodity index, which can be complex due to factors like contango and backwardation. According to MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57, such products embedding derivatives and complex structures are classified as complex. The product fails the criteria for non-complex instruments under Article 57, including the presence of derivatives, potential liabilities exceeding acquisition cost, and complexity of payoff and underlying. Therefore, it requires an appropriateness assessment before sale to retail investors. This aligns with ESMA guidance that synthetic ETFs and structured products with embedded derivatives are complex and require investor protection measures. Hence, the classification is complex under MiFID II rules."
}